cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Amneal Pharmaceuticals Inc
19 own
28 watching
Current Price
$5.52
$-0.17
(-2.99%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
1,077.95M
52-Week High
52-Week High
6.46000
52-Week Low
52-Week Low
1.33000
Average Volume
Average Volume
2.18M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
84.6746
iconMarket Capitalization1,077.95M
icon52-Week High6.46000
icon52-Week Low1.33000
iconAverage Volume2.18M
iconDividend Yield--
iconP/E Ratio84.6746
What does the Amneal Pharmaceuticals Inc do?
Amneal Pharmaceuticals, Inc., formerly known as Atlas Holdings, Inc. (the "Company"), was formed along with its wholly owned subsidiary, K2 Merger Sub Corporation, a Delaware corporation ("Merger Sub"), on October 4, 2017, for the purpose of facilitating the combination of Impax Laboratories, Inc. (now Impax Laboratories, LLC), a Delaware corporation then listed on the Nasdaq Stock Market ("Impax") and Amneal Pharmaceuticals LLC, a Delaware limited liability company ("Amneal").
Read More
How much money does Amneal Pharmaceuticals Inc make?
News & Events about Amneal Pharmaceuticals Inc.
TipRanks Financial Blog
9 months ago
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Amneal Pharmaceuticals (AMRX Research Report), Replimune Group ... Analysts have been eager to weigh in on the Healthcare sector with new ratings on Amneal Pharmaceuticals (AMRX Research Report), Replimune Group...
PR Newswire
9 months ago
Thinking about buying stock in Oncolytics Biotech, Eos Energy Enterprises, Rivian Automotive, Carnival Corp, or Amneal Pharmaceuticals? Thinking about buying stock in Oncolytics Biotech, Eos Energy Enterprises, Rivian Automotive, Carnival Corp, or Amneal Pharmaceuticals? PR Newswire NEW YORK, July...
Business Wire
9 months ago
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (Amneal or the Company) today announced it has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding the Companys New Drug Application (NDA) for IPX203 for the treatment of Parkinsons disease. The letter...
Business Wire
9 months ago
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (Amneal or the Company) today announced the launch of its authorized generic for Xyrem1 (Sodium Oxybate) oral solution CIII in the United States. Sodium Oxybate oral solution, 0.5 g/mL is a central nervous system depressant indicated for the treatment of...
Tickeron - Stocks
9 months ago
This is a signal that AMRX's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...
Frequently Asked Questions
Frequently Asked Questions
What is Amneal Pharmaceuticals Inc share price today?
plus_minus_icon
Can Indians buy Amneal Pharmaceuticals Inc shares?
plus_minus_icon
How can I buy Amneal Pharmaceuticals Inc shares from India?
plus_minus_icon
Can Fractional shares of Amneal Pharmaceuticals Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Amneal Pharmaceuticals Inc stocks?
plus_minus_icon
What is today’s traded volume of Amneal Pharmaceuticals Inc?
plus_minus_icon
What is today’s market capitalisation of Amneal Pharmaceuticals Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Amneal Pharmaceuticals Inc?
plus_minus_icon
What percentage is Amneal Pharmaceuticals Inc down from its 52-Week High?
plus_minus_icon
What percentage is Amneal Pharmaceuticals Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$5.52
$-0.17
(-2.99%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00